HER2-positive Biliary Tract Cancer
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18411 | Anbenitamab | 2 | Not Yet Recruiting | 1 |
| DB17446 | Erfonrilimab | 2 | Not Yet Recruiting | 1 |
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB18411 | Anbenitamab | 2 | Not Yet Recruiting | 1 |
| DB17446 | Erfonrilimab | 2 | Not Yet Recruiting | 1 |